An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.
Exscientia ends cancer study as it focuses on other trials of AI-driven drug candidates
AI drug discovery and development company Exscientia is stopping a solid tumor trial as it refocuses its internal pipeline amid plans to ink another partnership